{"Name":"Impax Laboratories","perma":"impax-laboratories","BasicInfo":{"funded":"1993-01-01","isClosed":false,"closed":null,"short":"Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company. The Company is focused on the development and"},"FundingRounds":[],"Acquisitions":[{"price":700000000,"paymentType":"cash","announcedDate":"2014-10-09","acquireeName":"Tower Holdings"}],"AcquiredBy":null,"IPO":{"exchange":"NASDAQ","symbol":"IPXL","shares":null,"date":"2003-01-10","openPrice":null,"moneyRaised":null,"valuation":null},"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[{"title":"President, CEO, Director","started":null,"ended":null,"firstName":"Larry","lastName":"Hsu"},{"title":"CFO","started":null,"ended":null,"firstName":"Arthur","lastName":"A. Koch Jr."}],"PastTeam":[{"title":"Senior Director of Intellectual Property","started":"2007-09-01","ended":"2011-07-01","firstName":null,"lastName":null}]}
